Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCl) is an essential electrolyte used to treat and prevent hypokalemia. It is available in various oral and intravenous formulations.
## Primary Indications
* Treatment and prevention of hypokalemia.
* Potassium replacement in patients with significant potassium losses (e.g., diuretic use, vomiting, diarrhea).
## Adult Dosing
* **Oral:**
* **Prevention:** 20 mEq (1.5 g KCl) daily in 1-2 divided doses.
* **Treatment:** 40-100 mEq (3-7.5 g KCl) daily in 2-4 divided doses. Maximum recommended daily oral dose is generally 200 mEq.
* *Note:* Specific dosing is often guided by serum potassium levels and clinical status. Extended-release formulations are typically dosed once or twice daily.
* **Intravenous (IV):**
* Dosing depends on serum potassium level and severity of hypokalemia.
* **Mild hypokalemia (serum K+ 3.0-3.5 mEq/L):** 20-40 mEq added to IV fluids, infused over 2-6 hours.
* **Moderate hypokalemia (serum K+ 2.5-2.9 mEq/L):** 40-60 mEq added to IV fluids, infused over 2-6 hours.
* **Severe hypokalemia (serum K+ <2.5 mEq/L) or ECG changes:** May require higher doses, faster infusion rates (up to 10-20 mEq/hour via peripheral line, faster via central line), and close cardiac monitoring. Maximum infusion rate for peripheral lines is generally 10 mEq/hour; for central lines, it can be up to 20 mEq/hour.
* *Note:* IV potassium administration is a critical care skill. Dosing and infusion rates must be individualized and closely monitored. Local hospital protocols often guide IV potassium administration. Maximum single IV doses and total daily doses vary. A common maximum daily IV dose is 200-400 mEq.
## Pediatric Dosing
* **Oral:**
* **Prevention:** 1-2 mEq/kg/day, not to exceed 20 mEq/day.
* **Treatment:** 2-5 mEq/kg/day in 2-4 divided doses, not to exceed 20 mEq/dose or 200 mEq/day.
* **Intravenous (IV):**
* Dosing and infusion rates are highly individualized based on serum potassium, weight, and clinical status.
* Generally, infusion rates should not exceed 10 mEq/kg/hour or 20 mEq/hour, whichever is less.
* *Note:* IV potassium administration in pediatrics requires extreme caution and close monitoring. Pediatric protocols should be followed.
## Dose Adjustments
* **Renal Impairment:** Use with extreme caution. Dose reduction or avoidance may be necessary. Monitor serum potassium levels closely.
## Contraindications
* Hyperkalemia.
* Conditions where oral KCl can cause gastrointestinal obstruction or perforation (e.g., slow intestinal transit, active peptic ulcer disease).
* Untreated Addison's disease.
* Severe renal impairment.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, abdominal pain, diarrhea, flatulence. Oral formulations can cause esophageal or gastric irritation, ulceration, bleeding, or perforation, especially if not taken with sufficient fluid or if the patient has delayed gastric emptying.
* **Cardiovascular:** Arrhythmias, cardiac arrest (primarily with rapid IV infusion or hyperkalemia).
* **Neuromuscular:** Paresthesias, weakness, paralysis.
* **Other:** Hyperkalemia.
## Key Drug Interactions
* **ACE inhibitors, ARBs, potassium-sparing diuretics (e.g., spironolactone, amiloride), NSAIDs, cyclosporine, tacrolimus:** Increased risk of hyperkalemia.
* **Corticosteroids:** May potentiate potassium loss with chronic use.
* **Anticholinergic agents:** May slow GI transit, increasing the risk of GI irritation/perforation with oral KCl.
## Monitoring
* Serum potassium levels (frequently, especially during initiation, dose changes, or with risk factors for hyperkalemia).
* Renal function (serum creatinine, BUN).
* ECG (especially with IV administration or suspected hyperkalemia).
* Signs and symptoms of hypokalemia (weakness, fatigue, constipation, arrhythmias) and hyperkalemia (muscle weakness, paresthesias, bradycardia, hypotension).
* Fluid balance.
## Clinical Pearls
* Oral potassium chloride should always be taken with a meal or sufficient fluid to minimize gastrointestinal irritation.
* Dilute IV potassium chloride appropriately before administration.
* Never administer IV potassium chloride undiluted as a bolus due to the high risk of cardiac arrest.
* Patients with renal impairment are at significantly higher risk of developing hyperkalemia.
* Be aware of potassium content in other medications and intravenous fluids to avoid inadvertent potassium overload.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions. Dosing and recommendations may vary based on individual patient factors, institutional protocols, and evolving medical knowledge.*
